الدكتور عفيف بن محمود
باحث أول مشارك
الدكتور عفيف بن محمود
باحث أول مشارك
المؤهلات العلمية
PhD (Molecular and Human Genetics)
Masters (Genetics and Biodiversity)
الكيان
معهد قطر لبحوث الطب الحيوي
Divison
مركز بحوث الاضطرابات العصبية
السيرة الذاتية
Dr. Afif Ben-Mahmoud holds expertise in the field of human molecular genetics, with years of experience in research and academia. He holds an Engineering degree in animal production, a Master's in genetics and biodiversity, and a Ph.D. in molecular and human genetics.
Dr. Ben-Mahmoud's research focuses on elucidating the cellular and molecular mechanisms underlying human genetic diseases, and on identifying disease genes and mutations responsible for rare recessive disorders in Arab populations. He has published over 20 original articles in top-tier international peer-reviewed journals.
Significant accomplishments include performing the first B3GALTL functional analysis in Tunisian patients with Peters Plus Syndrome, identifying MAST1 as a novel intellectual disability disease gene, confirming the involvement of B3GALT6 in the pathogenesis of Al-Gazali Syndrome, and identifying 16 autosomal dominant candidate genes in syndromic neurodevelopmental disorders. All this new research has broadened the understanding of genetic diseases and has been of immense help to the medical community.
PhD (Molecular and Human Genetics)
Faculty of Sciences. Sfax University-Tunisia.
2015
Masters (Genetics and Biodiversity)
Higher Institute of Biotechnology of Monastir-Tunisia.
2009
Engineer (Animal Production)
Higher School of Agronomy of Mateur-Tunisia.
2007
- Identification of autism genes and their underlying mechanism in Qatar
- Disease gene discovery in autosomal dominant syndromic and non-syndromic autism and intellectual disability
Senior Research Associate
Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar.
2019 - present
PostDoc Researcher
College of Medicine & Health Sciences, Pathology department, Al-Ain, UAE University, UAE.
2016 - 2018
2018; Researchers at UAEU develop cell lines with gene-editing technology CRISPR-Cas9 used to understand diseases www.uaeu.ac.ae